Foghorn Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is discovering and developing a novel class of precision medicine therapeutics targeting the chromatin regulatory system in oncology. Through its scalable Gene Traffic Control product platform, the firm is systematically interrogating and drugging the chromatin regulatory system. The company was founded by Cigall Kadoch, Gerald W. Crabtree and Douglas G. Cole in October 2015 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
112
Frequently Asked Questions
What is Market Cap of Foghorn Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Foghorn Therapeutics Inc market cap is $326.18M.
What is the 52-week high for Foghorn Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Foghorn Therapeutics Inc 52 week high is $10.25 as of September 07, 2025.
What is the 52-week low for Foghorn Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Foghorn Therapeutics Inc 52 week low is $2.94 as of September 07, 2025.
What is Foghorn Therapeutics Inc stock price today?
Foghorn Therapeutics Inc stock price today is $5.77.
What was Foghorn Therapeutics Inc stock price yesterday?
Foghorn Therapeutics Inc stock price yesterday was $5.39.
What is the PE ratio of Foghorn Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Foghorn Therapeutics Inc’s P/E ratio is -4.65.
What is the Price-to-Book ratio of Foghorn Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Foghorn Therapeutics Inc P/B ratio is -4.2002.
What is the 50-day moving average of Foghorn Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Foghorn Therapeutics Inc 50-day moving average is $5.35.
How many employess does Foghorn Therapeutics Inc has?